In 2011, Nexus Pharmaceuticals opened a 5,000 square foot full-service R&D lab. By conducting our own research and testing in-house in our FDA-approved lab, we’re able to have better control over our products’ quality. It helps us deliver on our mission of providing generic injectables that are safe, affordable, reliable and available.

Nexus Pharmaceuticals has a number of generic medicines in a variety of therapeutic classes in the pipeline. Our highly experienced researchers work on creating difficult-to-formulate generics using technologically advanced methods. Backed by our strong knowledge of chemistry, industry expertise and state-of-the-art technology, we are able to bring new generic injectable medicines to market quickly and at a reasonable cost.

The lab is located in Mundelein, Illinois, a short distance from the company’s headquarters. As part of the company’s overall growth, Nexus Pharmaceuticals plans to expand the lab’s size and staffing within the next year.

A commitment to providing safe, affordable generic medicines.